
Evozyne is a biotechnology company that creates novel protein systems aimed at solving longstanding challenges in therapeutic development. By leveraging advanced protein design and generative AI, Evozyne enhances protein performance to enable commercial-scale solutions, contributing to a healthier world. The company is well-funded and collaborates with top-tier investors and scientific advisors, positioning itself strongly in the biotech market focused on innovative therapeutic solutions.

Evozyne is a biotechnology company that creates novel protein systems aimed at solving longstanding challenges in therapeutic development. By leveraging advanced protein design and generative AI, Evozyne enhances protein performance to enable commercial-scale solutions, contributing to a healthier world. The company is well-funded and collaborates with top-tier investors and scientific advisors, positioning itself strongly in the biotech market focused on innovative therapeutic solutions.
Headquarters: Chicago, Illinois
Founded: 2020
Core tech: Generative AI (EvoGen) + high-throughput experimental biology (EvoLab)
Focus: De novo therapeutic protein design for immune-mediated diseases
Reported funding: Approximately $144.4M (across 3 rounds); Series B on 2023-09-27
| Company |
|---|
Therapeutic protein design for immune-mediated and IgG-mediated diseases, including indications like inflammatory bowel disease.
2020
Biotechnology
Reported as most recent round; Crunchbase lists total of three rounds aggregating ~$144.4M.
“Backed by institutional investors including Fidelity, OrbiMed, Valor Equity Partners, Paragon Biosciences”
Evozyne designs and builds engineered protein therapeutics using our AI-native platform, transforming what’s possible in immune-mediated disease treatment. Our scientists work at the intersection of biology, protein engineering, and AI to turn bold ideas into therapies that can meaningfully improve patients’ lives. This posting helps us connect with candidates for future opportunities. While this listing is not tied to a current opening, we encourage you to join our talent community so we can connect with you when new roles emerge!
Key Responsibilities
Who You Are
You thrive in an early-stage start-up environment and are motivated by the opportunity to build new medicines that can transform patients’ lives. You combine agility with scientific rigor to deliver high-quality results, and you bring natural curiosity and a collaborative mindset to solving complex challenges.
Background + Experience